# DoD Peer Reviewed, Convergent Science Cancer Consortium Development Award

Source: https://welltoldgrants.com/grants/w81xwh-22-prcrp-csccda-dod-peer-reviewed-convergent-science-cancer-consortium/  
Official notice: https://www.grants.gov/search-results-detail/339068

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make about 3 awards worth $12.0 million in total. Applications closed on September 7, 2022.

| Field | Value |
|---|---|
| Opportunity number | W81XWH-22-PRCRP-CSCCDA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | September 7, 2022 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 3 |
| Total funding | $12.0 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

The PRCRP seeks to promote novel approaches to ending cancer through convergent science cancer research. This effort will be executed through two separate award mechanisms, the Convergent Science Cancer Consortium Development Award in FY22 and the anticipated Convergent Science Cancer Consortium Award in FY24. Convergent science as defined by the National Science Foundation (https://www.nsf.gov/od/oia/convergence/index.jsp ) “is a means of solving vexing research problems, in particular, complex problems focusing on societal needs. It entails integrating knowledge, methods, and expertise from different disciplines and forming novel frameworks to catalyze scientific discovery and innovation.” Convergent science taps into a variety of disciplines to answer the issues in cancer (i.e., prevention, diagnosis/detection, treatment, quality of life) including but not limited to biomedical sciences, data science, engineering, psychology, and chemistry. As a more holistic approach, convergent science offers clinicians, scientists, and patients the opportunity to fight cancer on various fronts beyond what is offered by multidisciplinary approaches by merging sciences together. Convergent science breaks down the barriers of cancer research and builds a whole answer with tools from different areas of expertise. Initiatives such as the Cancer Moonshot aim to decrease the death rate of cancer by 50% over the next 25 years and improve the experience of patients, their families, and caregivers. The goals set by initiatives such as the Cancer Moonshot require innovative and unique approaches to ending cancer. The FY22 Convergent Science Cancer Consortium Development Award and the anticipated FY24 Convergent Science Cancer Consortium Award answer the call to find ground-breaking ways through convergent science research to improve quality of life by decreasing the burden of cancer on Service Members, their families, Veterans, and the American public. The eligible applicants of the FY22 Convergent Science Cancer Consortium Development Award are expected to submit an application to compete for the Convergent Science Cancer Consortium Award anticipated to be offered in FY24. The PRCRP expects to fund three FY22 Convergent Science Cancer Consortium Development Awards, depending on the number and the quality of applications received.

## Questions people ask

### Is W81XWH-22-PRCRP-CSCCDA still open?

No. It closed on September 7, 2022. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DoD Peer Reviewed, Convergent Science Cancer Consortium Development Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DoD Peer Reviewed, Convergent Science Cancer Consortium Development Award?

Closed September 7, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $12.0 million in total across about 3 awards.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.